American Century Companies’s Blueprint Medicines BPMC Stock Holding History

American Century Companies’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-22,770	Closed	-$2.92M	–	2795
2025 Q2	$2.92M	Sell	22,770 -843,993	-97%	-$87.7M	﹤0.01%	1896
2025 Q1	$76.7M	Buy	866,763 +27,560	+3%	+$2.69M	0.05%	422
2024 Q4	$73.2M	Buy	839,203 +24,132	+3%	+$2.21M	0.04%	450
2024 Q3	$75.4M	Buy	815,071 +12,338	+2%	+$1.23M	0.04%	430
2024 Q2	$86.5M	Buy	802,733 +32,600	+4%	+$3.26M	0.05%	367
2024 Q1	$73.1M	Buy	770,133 +58,399	+8%	+$5.01M	0.05%	423
2023 Q4	$65.7M	Buy	711,734 +40,762	+6%	+$2.64M	0.05%	418
2023 Q3	$33.7M	Buy	670,972 +33,243	+5%	+$1.78M	0.03%	590
2023 Q2	$40.3M	Buy	637,729 +23,008	+4%	+$1.25M	0.03%	512
2023 Q1	$26.6M	Sell	614,721 -1,571	-0.3%	-$70.8K	0.02%	634
2022 Q4	$27M	Buy	616,292 +6,036	+1%	+$289K	0.02%	617
2022 Q3	$40.2M	Sell	610,256 -24,439	-4%	-$1.57M	0.04%	448
2022 Q2	$32.1M	Sell	634,695 -122,030	-16%	-$7.15M	0.03%	526
2022 Q1	$48.3M	Sell	756,725 -108,056	-12%	-$7.76M	0.03%	457
2021 Q4	$92.6M	Sell	864,781 -443	-0.1%	-$46.3K	0.06%	341
2021 Q3	$89M	Buy	865,224 +63,302	+8%	+$5.89M	0.06%	326
2021 Q2	$70.5M	Sell	801,922 -30,640	-4%	-$2.81M	0.05%	396
2021 Q1	$81M	Buy	832,562 +81,466	+11%	+$8.13M	0.06%	337
2020 Q4	$84.2M	Buy	751,096 +15,057	+2%	+$1.59M	0.07%	287
2020 Q3	$68.2M	Buy	736,039 +33,460	+5%	+$2.58M	0.06%	299
2020 Q2	$54.8M	Buy	702,579 +182,618	+35%	+$12.4M	0.05%	328
2020 Q1	$30.4M	Sell	519,961 -24,866	-5%	-$1.6M	0.04%	381
2019 Q4	$43.6M	Buy	544,827 +140,717	+35%	+$10.5M	0.04%	371
2019 Q3	$29.7M	Buy	404,110 +3,964	+1%	+$343K	0.03%	422
2019 Q2	$37.7M	Buy	400,146 +65,488	+20%	+$5.41M	0.04%	413
2019 Q1	$26.8M	Buy	334,658 +63,098	+23%	+$4.66M	0.03%	453
2018 Q4	$14.6M	Buy	271,560 +186,852	+221%	+$11.4M	0.02%	524
2018 Q3	$6.61M	Buy	84,708 +25,726	+44%	+$1.79M	0.01%	782
2018 Q2	$3.74M	Buy	58,982 +16,197	+38%	+$1.29M	﹤0.01%	908
2018 Q1	$3.92M	Buy	+42,785	New	+$3.69M	﹤0.01%	885
2016 Q3	–	Sell	-22,452	Closed	-$455K	–	1335
2016 Q2	$455K	Buy	+22,452	New	+$408K	﹤0.01%	1255

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

American Century Companies's BPMC Position: Q3 2025 in Review

American Century Companies sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 22,770 shares — an estimated $2.92M sold.

American Century Companies first reported a position in BPMC in Q2 2016 and held it in 31 quarters. The position peaked at $92.6M in Q4 2021. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

American Century Companies reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
American Century Companies sold 22,770 Blueprint Medicines shares in Q3 2025, an estimated $2.92M.
American Century Companies first reported a position in Blueprint Medicines in Q2 2016 and held it in 31 quarters.
American Century Companies's Blueprint Medicines position peaked at $92.6M in Q4 2021.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on American Century Companies's 13F filing for Q3 2025, filed 12 Nov 2025.